The CSF levels of total-tau and phosphotau in patients with relapsing-remitting multiple sclerosis

Journal of Neural Transmission

Volumn 113, Issue 3, 2006, Pages 339-345

  Bartosik Psujek, H ^a   Stelmasiak, Z ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Multiple sclerosis; Phosphotau protein; Tau protein

Indexed keywords

TAU PROTEIN;

ADULT; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; STATISTICAL SIGNIFICANCE;

ADULT; BIOLOGICAL MARKERS; BRAIN; CEREBROSPINAL FLUID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MICROTUBULES; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PHOSPHORYLATION; PREDICTIVE VALUE OF TESTS; TAU PROTEINS; UP-REGULATION; WALLERIAN DEGENERATION;

EID: 32044465537     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-005-0327-z     Document Type: Article

References (25)

1. H Bartosik-Psujek JJ Archelos 2004 Tau protein and 14-3-3 are elevated in the cerebrospinal fluid of patients with multiple sclerosis and correlate with intrathecal synthesis of IgG. J Neurol 251 414 420
2. K Blennow A Wallin H Agren C Spenger J Siegfried E Vanmechelen 1995 Tau protein in cerebrospinal fluid: a biochemical diagnostic marker for axonal degeneration in Alzheimer's disease? Mol Chem Neuropathol 26 231 245
3. M Blomberg M Jensen H Basun L Lannfelt LO Wahlund 2001 Cerebrospinal fluid tau levels increase with age in healthy individuals. Dement Geriatr Cogn Disord 12 127 132
4. R Brandt M Hundelt N Shahani 2005 Tau alteration and neuronal degeneration in tauopathies: mechanisms and models. Biochim Biophys Acta 1739 331 354
5. K Buerger R Zinkowski SJ Teipel T Tapiola H Arai K Blennow N Andreasen K Hofmann-Kiefer J DeBernardis D Kerkman C [tmp] McCulloch R Kohnken F Padberg T Pirttila MB Schapiro SI Rapoport HJ Moller P Davies H Hampel 2002 Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231. Arch Neurol 59 1267 1272
6. M Colucci L Roccatagliata E Capello E Narciso N Latronico M Tabaton GL Mancardi 2004 The 14-3-3 protein in multiple sclerosis: a marker of disease severity. Mult Scler 10 477 481
7. J Eidenmuller R Brandt 2002 Tau-mediated cytotoxicity in pseudohyperphosphorylation model of Alzheimer's disease. J Neurosci 22 9733 9741
8. M Goedert 1993 Tau protein and the neurofibrillary pathology of Alzheimer's disease. Trends Neurosci 16 460 465
9. F Hulstaert K Blennow A Ivanoiu HC Schoondrewaldt M Riemenschneider PP de Deyn C Bancher P Cras J Wiltfang PD Mehta K Iqbal H Pottel E Vanmechelen H Vanderstichele 1999 Improved discrimination of AD patients using ß-amyloid (1-42) and tau levels in CSF. Neurology 52 1555 1562
10. FJ Jimenez-Jimenez JM Zurdo A Hernanz S Medina-Acebron F De Bustos B Barcenilla Y Sayed L Ayuso-Peralta 2002 Tau protein concentrations in cerebrospinal fluid of patients with multiple sclerosis. Acta Neurol Scand 106 351 354
11. E Kapaki GP Paraskevas M Michalopoulu K Kilidireas 2000 Increased cerebrospinal fluid tau protein in multiple sclerosis. Eur Neurol 43 228 232
12. T Kuhlmann G Lingfeld A Bitsch J Schuchardt W Bruck 2002 Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain 125 2202 2212
13. A Maddalena A Papassotiropoulos B Muller-Tillmanns HH Jung T Hegi RM Nitsch C Hock 2003 Biochemical diagnosis of Alzheimer disease by measuring the cerebrospinal fluid ratio of phosphorylated tau protein to beta-amyloid peptide42. Arch Neurol 60 1202 1206
14. A Martinez-Yelamos A Saiz J Bas JJ Hernandez F Graus T Arbizu 2004 Tau protein in cerebrospinal fluid: a possible marker of poor outcome in patients with early relapsing-remitting multiple sclerosis. Neurosci Lett 363 14 17
15. WI [tmp] McDonald A Compston G Edan D Goodkin HP Hartung FD Lublin HF [tmp] McFarland DW Paty CH Polman SC Reingold M Sandberg-Wollheim W Sibley A Thompson S van den Noort BY Weinshenker JS Wolinsky 2001 Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50 121 127
16. M Otto J Wiltfang H Tumani I Zerr M Lantsch J Kornhuber T Weber HA Kretzschmar S Poser 1997 Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Neurosci Lett 225 210 212
17. L Parnetti A Lanari S Amici V Gallai E Vanmechelen F Hulstaert 2001 CSF phosphorylated tau is a possible marker for discriminating Alzheimer's disease from dementia with Lewy bodies. Phospho-Tau International Study Group. Neurol Sci 22 77 78
18. M Riemenschneider S Wagenpfeil H Vanderstichele M Otto J Wiltfang H Kretzschmar E Vanmechelen H Forstl A Kurz 2003 Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias. Mol Psychiatry 8 343 347
19. SM Rosso E van Herpen YA Pijnenburg NS Schoonenboom P Scheltens P Heutink JC van Swieten 2003 Total tau and phosphorylated tau 181 levels in the erebrospinal fluid of patients with frontotemporal dementia due to P301∈L and G272∈V tau mutations. Arch Neurol 60 1209 1213
20. A Schneider GW Araujo K Trajkovic MM Herrmann D Merkler EM Mandelkow R Weissert M Simons 2004 Hyperphosphorylation and aggregation of tau in experimental autoimmune encephalomyelitis. J Biol Chem 279 55833 55839
21. GA Schumacher 1974 Critique of experimental trials of therapy in multiple sclerosis. Neurology 24 1010 1014
22. N Shahani R Brandt 2002 Functions and malfunctions of the tau proteins. Cell Mol Life Sci 59 1668 1680
23. SD Süssmuth H Reiber H Tumani 2001 Tau protein in cerebrospinal fluid (CSF): a blood-CSF barrier related evaluation in patients with neurological diseases. Neurosci Lett 300 95 98
24. CW Wittmann MF Wszolek JM Shulman PM Salvaterra J Lewis M Hutton MB Feany 2001 Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles. Science 293 711 714
25. H Zetterberg K Blennow 2004 Elevated total tau/phospho-tau ratio in autopsy-proven Creutzfeldt-Jakob disease with negative 14-3-3 test results. Neurol Sci 25 301 302